Tim Wilsdon recently presented at an education forum at ISPOR Latin America, talking about the challenges that gene therapy poses for value assessment and considerations for the future.
For more information about the conference, click here.
Inequities in patient support, well-being, and treatment access for triple negative breast cancer patients
In this report, Charles River Associates (CRA) and Cancer Support Community (CSC) examine the extent to which policies associated with long-term support,...